Sylvia Adams

NYU Langone Health — United States

Medicine · Health Sciences

72h-index31.0kcitations351works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(156), Immunotherapy and Immune Responses(83), Advanced Breast Cancer Therapies(62), Chronic Obstructive Pulmonary Disease (COPD) Research(45), Cancer Genomics and Diagnostics(39)

Publications330 total

Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study
Journal of Cancer Research and Clinical Oncology·2025· 4 citedOpen Access
B – 60 Subjective Cognitive Function and Quality of Life Improvements Following Auditory-Based Cognitive Training in Breast Cancer Survivors: A Subgroup Feasibility Analysis
Archives of Clinical Neuropsychology·2025
Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer
Proceedings of the National Academy of Sciences·2025· 3 citedOpen Access
Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer
Frontiers in Oncology·2025Open Access
Immunotherapy vs. chemotherapy run-in followed by pembrolizumab plus nab-paclitaxel in metastatic triple negative breast cancer (mTNBC): Results from a phase II study.
Journal of Clinical Oncology·2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer
Journal for ImmunoTherapy of Cancer·2025· 6 citedOpen Access
XMT-1660: A phase I, first-in-human trial of a B7-H4-directed dolasynthen antibody-drug conjugate in ovarian, endometrial, and breast cancers
Gynecologic Oncology·2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).
UNC Libraries·2024Open Access
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer
Journal of Clinical Oncology·2024· 16 cited
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
JCO Oncology Practice·2024· 11 citedOpen Access
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
JAMA Oncology·2024· 35 citedOpen Access
Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment
UNC Libraries·2024Open Access
Predicting completion of endocrine therapy for older patients with early-stage breast cancer.
Journal of Clinical Oncology·2024
Abstract PO1-28-10: Tumor Infiltrating Lymphocytes identify patients with stage I TNBC with excellent outcome without chemotherapy
Cancer Research·2024· 1 cited
The tumor immune environment in advanced breast cancer following treatment with pembrolizumab and nab-paclitaxel
The Journal of Immunology·2024
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches
Journal of Neuro-Oncology·2024· 2 cited
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology·2024· 13 citedOpen Access
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation
Breast Cancer Research and Treatment·2024· 2 cited
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Medical Research Archives·2024Open Access
698 Safety and tolerability of magrolimab in combination with taxanes in patients with solid tumors
Regular and Young Investigator Award Abstracts·2023· 1 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Sherene Loi(21), Sandra Demaria(15), Roberto Salgado(12), Carsten Denkert(11), Sunil Badve(11), Stefan Michiels(11), Giancarlo Pruneri(10), Giuseppe Viale(10), David L. Rimm(9), Sibylle Loibl(9), Christos Sotiriou(9), Hope S. Rugo(8), Hiroji Iwata(8), Eric P. Winer(8), Maria Vittoria Dieci(8), Stephen M. Hewitt(8), Peter Schmid(7), Luciana Molinero(7), Stephan Wienert(7), Joseph A. Sparano(7)